<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03266094</url>
  </required_header>
  <id_info>
    <org_study_id>MDT17024BZP</org_study_id>
    <nct_id>NCT03266094</nct_id>
  </id_info>
  <brief_title>A Study of BiZact™ on Children and Adolescents Undergoing Tonsillectomy</brief_title>
  <official_title>A Prospective, Multi-center, Single Arm Study of BiZact™ on Children and Adolescents Undergoing Tonsillectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess safety and performance with the use of the BiZact™
      device in tonsillectomy procedures in children and adolescents.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective, multi-center, single arm, study of BiZact™ on children and adolescents
      undergoing tonsillectomy.

      Study Visits:

        -  Screening/Baseline

        -  Surgery, Day 0

        -  Post-Op Follow-up Day 1 - Day 7, Day 10, &amp; Day 14 (Home assessments)

        -  Post-Op Follow-up Day 28 (Office Visit)
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2018</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intra-operative blood loss</measure>
    <time_frame>During procedure</time_frame>
    <description>The study will be considered a success if the mean intra-operative blood loss is less than the mean intra-operative blood loss associated with conventional tonsillectomy in a large meta-analysis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Performance of the investigational device (Ability to dissect tonsils)</measure>
    <time_frame>During Procedure</time_frame>
    <description>Ability to dissect tonsils with investigational device via Likert Scale (Very Good, Good, Acceptable, Poor, Very Poor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Performance of the investigational device (Ability to achieve hemostasis)</measure>
    <time_frame>During Procedure</time_frame>
    <description>Ability to achieve hemostasis (arrest of bleeding, as assessed by visual inspection of the Investigator) without the use of other interventions (e.g. energy device or sutures)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic consumption</measure>
    <time_frame>28 days post-operatively</time_frame>
    <description>Analgesic consumption (standard of care) and concomitant medications (via patient diary).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>Post-operative Day 1</time_frame>
    <description>Evaluation of post-operative pain incidence and severity measured using the Wong-Baker FACES® Pain Rating Scale or the FLACC behavioral pain rating scale (age dependent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>Post-operative Day 2</time_frame>
    <description>Evaluation of post-operative pain incidence and severity measured using the Wong-Baker FACES® Pain Rating Scale or the FLACC behavioral pain rating scale (age dependent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>Post-operative Day 3</time_frame>
    <description>Evaluation of post-operative pain incidence and severity measured using the Wong-Baker FACES® Pain Rating Scale or the FLACC behavioral pain rating scale (age dependent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>Post-operative Day 4</time_frame>
    <description>Evaluation of post-operative pain incidence and severity measured using the Wong-Baker FACES® Pain Rating Scale or the FLACC behavioral pain rating scale (age dependent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>Post-operative Day 5</time_frame>
    <description>Evaluation of post-operative pain incidence and severity measured using the Wong-Baker FACES® Pain Rating Scale or the FLACC behavioral pain rating scale (age dependent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>Post-operative Day 6</time_frame>
    <description>Evaluation of post-operative pain incidence and severity measured using the Wong-Baker FACES® Pain Rating Scale or the FLACC behavioral pain rating scale (age dependent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>Post-operative Day 7</time_frame>
    <description>Evaluation of post-operative pain incidence and severity measured using the Wong-Baker FACES® Pain Rating Scale or the FLACC behavioral pain rating scale (age dependent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>Post-operative Day 10</time_frame>
    <description>Evaluation of post-operative pain incidence and severity measured using the Wong-Baker FACES® Pain Rating Scale or the FLACC behavioral pain rating scale (age dependent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>Post-operative Day 14</time_frame>
    <description>Evaluation of post-operative pain incidence and severity measured using the Wong-Baker FACES® Pain Rating Scale or the FLACC behavioral pain rating scale (age dependent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>Post-operative Day 28</time_frame>
    <description>Evaluation of post-operative pain incidence and severity measured using the Wong-Baker FACES® Pain Rating Scale or the FLACC behavioral pain rating scale (age dependent)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Tonsillectomy</condition>
  <arm_group>
    <arm_group_label>Bipolar instrument for tonsillectomies</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>BiZact™: A bipolar instrument for tonsillectomies</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BiZact™: A bipolar instrument for tonsillectomies</intervention_name>
    <description>A bipolar electrosurgical device that employs RF energy and pressure to ligate vessels interposed between its jaws which can then be transected using the built in knife deployed by the device trigger.</description>
    <arm_group_label>Bipolar instrument for tonsillectomies</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children and adolescent subjects 2-21 years of age at the time of the procedure,
             inclusive

          -  Scheduled to undergo tonsillectomy

          -  The Subject or (if the subject is a minor) Subject's Parent/Legally Authorized
             Representative (LAR) is willing to participate and consents to participate, as
             documented by signed informed consent form and/ or assent form (as applicable)

        Exclusion Criteria:

          -  Subjects undergoing:

               1. Tonsillectomy as a result of cancer

               2. Unilateral tonsillectomy

          -  Subjects with:

               1. Known bleeding disorders

               2. Current peritonsillar abscess

               3. Craniofacial disorders

               4. Down's syndrome (Trisomy 21)

               5. Cerebral palsy

               6. Major heart disease (including but not limited to; right-sided heart failure,
                  left-sided heart failure, congestive heart failure, coronary artery disease,
                  arrhythmias, chronic heart failure, acute heart failure, etc.)

               7. Current tobacco use

          -  Subjects unable to comply with the required study follow-up visits

          -  Female subjects pregnant at time of procedure.

          -  The subject has comorbidities which, in the opinion of the Investigator, will not be
             appropriate for the study or the subject has an estimated life expectancy - The
             subject is participating or has participated in any drug or device research study
             within 30 days of enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tianna Aronson</last_name>
    <phone>(508) 261-6049</phone>
    <email>tianna.d.aronson@medtronic.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Southeast Clinical Research Associates, LLC</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angela Price</last_name>
      <phone>704-295-3393</phone>
    </contact>
    <investigator>
      <last_name>Eric Mair</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Coastal Pediatric Associates</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laura Grant</last_name>
      <phone>843-518-5642</phone>
    </contact>
    <investigator>
      <last_name>William Brand</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Womens and Children's Hospital</name>
      <address>
        <city>North Adelaide</city>
        <zip>5006</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Wabnitz</last_name>
    </contact>
    <investigator>
      <last_name>David Wabnitz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 16, 2017</study_first_submitted>
  <study_first_submitted_qc>August 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2017</study_first_posted>
  <last_update_submitted>April 5, 2018</last_update_submitted>
  <last_update_submitted_qc>April 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

